Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction

Process and Instructions

DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender offer (the “Offer”) by Harmony Biosciences Holdings, Inc. (“Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. (“Purchaser”), to purchase all outstanding shares of Zynerba common stock. The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.

Key Information to Know

Tender Deadline:

• Zynerba stockholders must tender their shares by 5:00 p.m., New York City time, on Tuesday, October 10, 2023. Please note that if you hold shares of Zynerba common stock through a broker or other nominee, they may have a processing cutoff that is prior to the tender deadline (e.g., October 5^th or 6^th), so it is important that you act now if you want to tender your shares.
  

How to Tender Your Shares:

• If you hold shares of Zynerba common stock through a broker, dealer, commercial bank, trust company or other nominee, you must instruct such broker or other nominee to tender your shares. Please contact your broker or other nominee promptly to allow sufficient time to tender.  Do not wait until the tender deadline to tender your shares as they may not be counted. Please note that, in some cases, your broker's or other nominee’s processing cutoff date may have changed since the Offer deadline was first announced, so take prompt action today to ensure your shares are properly tendered prior to any applicable processing cutoff.
  • Contact Information for Commonly Used Brokers:
    • Call TD Ameritrade at 888-723-8504, option 1
    • Call Fidelity at 800-343-3548
    • Call E-Trade at 1-800-387-2331
    • Contact Robinhood at https://robinhood.com/contact
      • Please include the stock symbol for the offer (ZYNE) and the number of shares you would like to tender.
    • Call Charles Schwab at 1-800-435-4000
    • Call Morgan Stanley at 1-888-454-3965
    • Call JP Morgan at 1-800-935-9935
    • Call Merrill, a Bank of America Company at 1-800-637-7455
  • If your broker is not listed above, please contact your broker’s customer service department and ask to speak with Corporate Actions. From there, you should be directed to someone who can help you.
• Zynerba stockholders should contact MacKenzie Partners, Inc., toll free by phone at 800-322-2885 or by email to [e-mail] with any questions or to request assistance with tendering shares.